![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems.
Refocusing pipeline to Phase 1 Dectin-2 agonist antibody BDC-3042 and next-generation Boltbody™ ISAC platform including new clinical candidate BDC- 4182 targeting Claudin 18.2Bolt to cease further...
Period † | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0003 | 0.0405405405405 | 0.74 | 0.75 | 0.7201 | 152413 | 0.74238637 | CS |
4 | -0.0197 | -2.59210526316 | 0.76 | 0.795001 | 0.7201 | 155953 | 0.75385447 | CS |
12 | -0.6297 | -45.9635036496 | 1.37 | 1.48 | 0.7201 | 234650 | 0.8898171 | CS |
26 | -0.2497 | -25.2222222222 | 0.99 | 1.56 | 0.7201 | 180437 | 1.00989989 | CS |
52 | -0.6297 | -45.9635036496 | 1.37 | 1.56 | 0.7201 | 142573 | 1.03676588 | CS |
156 | -16.4597 | -95.6959302326 | 17.2 | 19.285 | 0.7201 | 205927 | 3.55002733 | CS |
260 | -25.3597 | -97.1636015326 | 26.1 | 43.07 | 0.7201 | 214111 | 7.18370234 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions